nach oben

Erschienen in:

2021 | OriginalPaper | Buchkapitel

53. Intraokuläre Lymphome (engl. Intraocular lymphoma)

verfasst von : Sarah Coupland, Doris Jähne

Erschienen in: Entzündliche Augenerkrankungen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

ICD-9-Code 200.50 Primary central nervous system lymphoma, unspecified site, extranodal and solid organ sites

Alizadeh AA, Eisen MB, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503–511PubMedCrossRef

Angelov L, Doolittle ND, Kraemer DF et al (2009) Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol 27(21):3503–3509PubMedPubMedCentralCrossRef

Baryla J, Allen LH, Kwan K, Ong M, Sheidow T (2012) Choroidal lymphoma with orbital and optic nerve extension: case and review of literature. Can J Ophthalmol 47(1):79–81. https://doi.org/10.1016/j.jcjo.2011.12.017. PMID: 22333857

Ben-Ezra D, Sahel JA, Harris NL, Hemo I, Albert DM (1989) Uveal lymphoid infiltrates: immunohistochemical evidence for a lymphoid neoplasia. Br J Ophthalmol 73(10):846–851PubMedPubMedCentralCrossRef

Bonzheim I, Giese S, Deuter C et al (2015) High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. Blood 126:76–79PubMedCrossRef

Cani AK, Hovelson DH, Demirci H, Johnson MW, Tomlins SA, Rao RC (2017) Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies. Oncotarget 8(5):7989–7998PubMedCrossRef

Cassoux N, Merle-Beral H, Leblond V et al (2000) Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 8(4):243–250PubMedCrossRef

Chan CC (2003a) Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc 101:275–292PubMedPubMedCentral

Chan CC (2003b) Primary intraocular lymphoma: clinical features, diagnosis, and treatment. Clin Lymphoma 4(1):30–31. https://doi.org/10.1016/s1526-9655(11)70005-7. PMID: 12837151

Chan CC, Rubenstein JL, Coupland SE et al (2010) Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist 16(11):1589–1599CrossRef

Chanudet E, Huang Y, Ichimura K et al (2010) A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma. Leukemia 24(2):483–487PubMedCrossRef

Cheung MK, Martin DF, Chan CC, Callanan DG, Cowan CL, Nussenblatt RB (1994) Diagnosis of reactive lymphoid hyperplasia by chorioretinal biopsy. Am J Ophthalmol 118(4):457–462PubMedCrossRef

Ciulla TA, Bains RA, Jakobiec FA, Topping TM, Gragoudas ES (1997) Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form. Surv Ophthalmol 41(6):467–476PubMedCrossRef

Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM (2000) Re-evaluation of „reactive lymphoid hyperplasia of the uvea“: an immunohistochemical and molecular analysis of 10 cases. Ophthalmology 107(1):151–158PubMedCrossRef

Cooper EL, Riker JL (1951) Malignant lymphoma of the uveal tract. Am J Ophthalmol 34(8):1153–1158PubMedCrossRef

Coupland SE (2012) Vitreous biopsy: specimen preparation and interpretation. Monogr Clin Cytol 21:61–71PubMedCrossRef

Coupland SE (2013) Molecular pathology of lymphoma. Eye (Lond) 27(2):180–189CrossRef

Coupland SE, Damato B (2008) Understanding intraocular lymphomas. Clin Exp Ophthalmol 36(6):564–578PubMedCrossRef

Coupland SE, Foss HD, Assaf C et al (1999) T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Ophthalmology 106(11):2109–2120PubMedCrossRef

Coupland SE, Foss HD, Hidayat AA, Cockerham GC, Hummel M, Stein H (2002a) Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases. J Pathol 197(3):333–340PubMedCrossRef

Coupland SE, Hummel M, Stein H (2002b) Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv Ophthalmol 47(5):470–490. https://doi.org/10.1016/s0039-6257(02)00337-5. PMID: 12431695

Coupland SE, Anastassiou G, Bornfeld N, Hummel M, Stein H (2005) Primary intraocular lymphoma of T-cell type: report of a case and review of the literature. Graefes Arch Clin Exp Ophthalmol 243(3):189–97. https://doi.org/10.1007/s00417-004-0890-2. Epub 2004 Dec 10. PMID: 15806372

Coupland SE, Hummel M, Muller HH, Stein H (2005b) Molecular analysis of immunoglobulin genes in primary intraocular lymphoma. Invest Ophthalmol Vis Sci 46(10):3507–3514. https://doi.org/10.1167/iovs.05-0401. PMID: 16186327

Coupland SE, Joussen A, Anastassiou G, Stein H (2005c) Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report. Graefes Arch Clin Exp Ophthalmol 243(5):482–486PubMedCrossRef

Coupland SE, Dodson A, Liu H, Du MQ, Angi M, Damato BE (2012) Intraocular collision tumour: case report and literature review. Graefes Arch Clin Exp Ophthalmol

Cummings TJ, Stenzel TT, Klintworth G, Jaffe GJ (2005) Primary intraocular T-cell-rich large B-cell lymphoma. Arch Pathol Lab Med 129(8):1050–1053.PubMedCrossRef

Davis JL (2013) Intraocular lymphoma: a clinical perspective. Eye (Lond) 27(2):153–162. https://doi.org/10.1038/eye.2012.250. Epub 2012 Nov 30. PMID: 23196650; PMCID: PMC3574250

Davis JL, Miller DM, Ruiz P (2005) Diagnostic testing of vitrectomy specimens. Am J Ophthalmol 140(5):822–829PubMedCrossRef

Deangelis LM, Hormigo A (2004) Treatment of primary central nervous system lymphoma. Semin Oncol 31(5):684–692PubMedCrossRef

Du MQ (2001) MALT lymphoma: many roads lead to nuclear factor-kappab activation. Histopathology 58(1):26–38. https://doi.org/10.1111/j.1365-2559.2010.03699.x. PMID: 21261681

Du MQ (2011) MALT lymphoma: many roads lead to nuclear factor-κb activation. Histopathology. 2011 Jan; 58(1):26–38. https://doi.org/10.1111/j.1365-2559.2010.03699.x. PMID: 21261681

Ferreri AJ, Blay JY, Reni M et al (2002) Relevance of intraocular involvement in the management of primary central nervous system lymphomas. Ann Oncol 13(4):531–538PubMedCrossRef

Ferry JA, Fung CY, Zukerberg L et al (2007) Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 31(2):170–184PubMedCrossRef

Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA (1997) Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 115(9):1152–1156PubMedCrossRef

Gass JD (1967) Retinal detachment and narrow-angle glaucoma secondary to inflammatory pseudotumor of the uveal tract. Am J Ophthalmol 64(3):612–621

Gass JD, Sever RJ, Grizzard WS (1984) Multifocal pigment epithelial detachments by reticulum cell sarcoma. A characteristic funduscopic picture. Retina 4:135–143PubMedCrossRef

Ghesquieres H, Chevrier M, Laadhari M, Chinot O, Choquet S, Moluçon-Chabrot C, Beauchesne P, Gressin R, Morschhauser F, Schmitt A, Gyan E, Hoang-Xuan K, Nicolas-Virelizier E, Cassoux N, Touitou V, Le Garff-Tavernier M, Savignoni A, Turbiez I, Soumelis V, Houillier C, Soussain C (2019) Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‚proof of concept‘ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA). Ann Oncol 30(4):621–628PubMedCrossRef

Goldey SH, Stern GA, Oblon DJ, Mendenhall NP, Smith LJ, Duque RE (1989) Immunophenotypic characterization of an unusual T-cell lymphoma presenting as anterior uveitis. A clinicopathologic case report. Arch Ophthalmol 107(9):1349–1353PubMedCrossRef

Grossniklaus HE, Martin DF, Avery R et al (1998) Uveal lymphoid infiltration. Report of four cases and clinicopathologic review. Ophthalmology 105(7):1265–1273PubMedCrossRef

Helbig H, Cerny T, de Smet MD (2003) Intravitreal chemotherapy for intraocular lymphoma. Ophthalmologe 100(2):145–149PubMedCrossRef

Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, Nierkens S, Ossewaarde-van Norel J, de Boer JH, Roholl FF, de Weger RA, Huibers MMH, de Groot-Mijnes JDF, Kuiper JJW (2018) Potential diagnosis of vitreoretinal lymphoma by detection of MYD88 mutation in aqueous humor with ultrasensitive droplet digital polymerase chain reaction. JAMA Ophthalmol 136(10):1098–1104PubMedPubMedCentralCrossRef

Holz FG, Boehmer HV, Mechtersheimer G, Ott G, Volcker HE (1999) Uveal non-Hodgkin’s lymphoma with epibulbar extension simulating choroidal effusion syndrome. Retina 19(4):343–346PubMedCrossRef

Itty S, Pulido JS (2009) Rituximab for intraocular lymphoma. Retina 29(2):129–132PubMedCrossRef

Jakobiec FA, Sacks E, Kronish JW, Weiss T, Smith M (1987) Multifocal static creamy choroidal infiltrates. An early sign of lymphoid neoplasia. Ophthalmology 94(4):397–406PubMedCrossRef

Jensen OA, Johansen S, Kiss K (1994) Intraocular T-cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Report of a case and survey of the literature. Graefes Arch Clin Exp Ophthalmol 232(3):148–152PubMedCrossRef

Kakkassery V, Schroers R, Coupland SE, Wunderlich MI, Schargus M, Heinz C, Wasmuth S, Heiligenhaus A, Ahle G, Lenoble P, Schlegel U, Schmiegel W, Dick HB, Baraniskin A (2017) Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma. Blood 129(23):3130–3133PubMedCrossRef

Kitzmann AS, Pulido JS, Mohney BG et al (2007) Intraocular use of rituximab. Eye (Lond) 21(12):1524–1527CrossRef

Levy-Clarke GA, Chan CC, Nussenblatt RB (2005) Diagnosis and management of primary intraocular lymphoma. Hematol Oncol Clin North Am 19(4):739–749PubMedCrossRef

Lobo A, Larkin G, Clark BJ, Towler HM, Lightman S (2003) Pseudo-hypopyon as the presenting feature in B-cell and T-cell intraocular lymphoma. Clin Exp Ophthalmol 31(2):155–158PubMedCrossRef

Malumbres R, Davis J, Ruiz P, Lossos IS (2007) Somatically mutated immunoglobulin IGHV@ genes without intraclonal heterogeneity indicate a postgerminal centre origin of primary intraocular diffuse large B-cell lymphomas. Br J Haematol 138(6):749–755PubMedCrossRef

Margolis L, Fraser R, Lichter A, Char DH (1980) The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 45(4):688–692PubMedCrossRef

McKelvie PA (2010) Ocular adnexal lymphomas: a review. Adv Anat Pathol 17(4):251–261PubMedCrossRef

Montesinos-Rongen M, Kuppers R, Schluter D et al (1999) Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol 155(6):2077–2086PubMedPubMedCentralCrossRef

Mudhar HS, Sheard R (2013) Diagnostic cellular yield is superior with full pars plana vitrectomy compared with core vitreous biopsy. Eye (Lond) 27(1):50–55CrossRef

Pe’er J, Hochberg FH, Foster CS (2009) Clinical review: treatment of vitreoretinal lymphoma. Ocul Immunol Inflamm 17(5):299–306PubMedCrossRef

Pels H, Montesinos-Rongen M, Schaller C et al (2005) VH gene analysis of primary CNS lymphomas. J Neurol Sci 228(2):143–147PubMedCrossRef

Portell CA, Aronow ME, Rybicki LA, Macklis R, Singh AD, Sweetenham JW (2014) Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype. Clin Lymphoma Myeloma Leuk. 14(3):203–210PubMedCrossRef

Raja H, Salomão DR, Viswanatha DS, Pulido JS (2016) Prevalence of MYD88 L265P mutation in histologically proven, diffuse large B-cell vitreoretinal lymphoma. Retina 36(3):624–628PubMedCrossRef

Raju VK, Green WR (1982) Reticulum cell sarcoma of the uvea. Ann Ophthalmol 14(6):555–560PubMed

Reid JP, Puglis CL, Slagle WS (2014) Intraocular mantle cell lymphoma of the iris. Optom Vis Sci 91(4 Suppl 1):S25–S29PubMedCrossRef

Ryan SJ Jr, Frank RN, Green WR (1971) Bilateral inflammatory pseudotumors of the ciliary body. Am J Ophthalmol 72(3):586–591PubMedCrossRef

Ryan SJ, Zimmerman LE, King FM (1972) Reactive lymphoid hyperplasia. An unusual form of intraocular pseudotumor. Trans Am Acad Ophthalmol Otolaryngol 76(3):652–671PubMed

Shields CL, Manalac J, Das C, Saktanasate J, Shields JA (2015) Review of spectral domain enhanced depth imaging optical coherence tomography of tumors of the choroid. Indian J Ophthalmol 63(2):117–121PubMedPubMedCentralCrossRef

Shiratori E, Itoh M, Tohda S (2017) MYD88 inhibitor ST2825 suppresses the growth of lymphoma and leukaemia cells. Anticancer Res 37(11):6203–6209PubMed

Soussain C, Choquet S, Blonski M, Leclercq D, Houillier C, Rezai K, Bijou F, Houot R, Boyle E, Gressin R, Nicolas-Virelizier E, Barrie M, Moluçon-Chabrot C, Lelez ML, Clavert A, Coisy S, Leruez S, Touitou V, Cassoux N, Daniau M, Ertault de la Bretonnière M, El Yamani A, Ghesquières H, Hoang-Xuan K (2019) Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‚proof-of-concept‘ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network. Eur J Cancer 117:121–130PubMedCrossRef

Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4. Aufl. IARC Press, Lyon

Tavallali A, Shields CL, Bianciotto C, Shields JA (2010) Eur J Ophthalmol 20(5):959–962PubMedCrossRef

Tiu Teo HM, Çiftçi S, Elner VM, Demirci H (2019) Systemic anti-CD20 (rituximab) as primary treatment for symptomatic primary uveal lymphoma. Am J Ophthalmol Case Rep 15:959–962

Treibenstein O (1920) Ein Beitrag zur Frage der aleukaemischen Augenveraenderungen. Klin Monatsbl Augenheilkd 64:825–836

Turaka K, Bryan JS, De Souza S et al (2012) Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution. Clin Lymphoma Myeloma Leuk 12(6):412–417PubMedCrossRef

Velez G, de Smet MD, Whitcup SM, Robinson M, Nussenblatt RB, Chan CC (2000) Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol 44(6):518–526PubMedCrossRef

Williams BK Jr, Tsui I, McCannel TA (2010) Spectral-domain optical coherence tomography of conjunctival mucosa-associated lymphoid tissue lymphoma with presumed choroidal involvement. Graefes Arch Clin Exp Ophthalmol 248(12):1837–1840PubMedPubMedCentralCrossRef

Yahalom C, Cohen Y, Averbukh E, Anteby I, Amir G, Pe’er J (2002) Bilateral iridociliary T-cell lymphoma. Arch Ophthalmol 120(2):204–207PubMed

Yamada K, Hirata A, Kimura A, Tanihara H (2003) A case of primary B-cell type non-Hodgkin lymphoma originating in the iris. Am J Ophthalmol 136(2):380–382PubMedCrossRef

Zhou N, Xu X, Liu Y, Wang Y, Wei W. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma. Eye (Lond). https://doi.org/10.1038/s41433-021-01657-0. Epub ahead of print. PMID: 34211136

Titel: (engl. Intraocular lymphoma)
verfasst von: Sarah Coupland
Doris Jähne
Verlag: Springer Berlin Heidelberg
Buch: Entzündliche Augenerkrankungen
Print ISBN: 978-3-662-60398-7

Electronic ISBN: 978-3-662-60399-4

Copyright-Jahr: 2021
DOI: https://doi.org/10.1007/978-3-662-60399-4_53

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

CME: Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Wird ein Glaukom chirurgisch behandelt, ist die anschließende Wundheilung von entscheidender Bedeutung. In diesem CME-Kurs lernen Sie, welche Pathomechanismen der Vernarbung zugrunde liegen, wie perioperativ therapiert und Operationsversagen frühzeitig erkannt werden kann.

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

53. Intraokuläre Lymphome (engl. Intraocular lymphoma)

Zusammenfassung

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Staging und Systemtherapie bei okulären und periokulären Metastasen

CME: Wundheilung nach Trabekulektomie

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Update Augenheilkunde